These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
361 related articles for article (PubMed ID: 31081117)
21. [Clinicopathologic and survival analysis of synchronous primary endometrial and ovarian cancer]. Wang Y; Yu M; Yang JX; Cao DY; Zhang Y; Shen K; You Y Zhonghua Fu Chan Ke Za Zhi; 2018 Dec; 53(12):816-822. PubMed ID: 30585019 [No Abstract] [Full Text] [Related]
22. The malignant transformation of endometriosis: Is there a left lateral predisposition of ovarian clear cell and endometrioid carcinomas? McMullan JC; Graham MJ; Craig EF; McCluggage WG; Hunter DH; Feeney L Eur J Surg Oncol; 2024 Jun; 50(6):108247. PubMed ID: 38522332 [TBL] [Abstract][Full Text] [Related]
23. Unraveling the two entities of endometrioid ovarian cancer: a single center clinical experience. Mangili G; Bergamini A; Taccagni G; Gentile C; Panina P; Viganò P; Candiani M Gynecol Oncol; 2012 Sep; 126(3):403-7. PubMed ID: 22609111 [TBL] [Abstract][Full Text] [Related]
24. Endometriosis-associated ovarian cancer: a different clinical entity. Leone Roberti Maggiore U; Bogani G; Paolini B; Martinelli F; Chiarello G; Spanò Bascio L; Chiappa V; Ferrero S; Ditto A; Raspagliesi F Int J Gynecol Cancer; 2024 Jun; 34(6):863-870. PubMed ID: 38531540 [TBL] [Abstract][Full Text] [Related]
26. Prognostic value of endometriosis in patients with stage I ovarian clear cell carcinoma: Experiences at three academic institutions. Bai H; Cao D; Yuan F; Sha G; Yang J; Chen J; Wang Y; Zhang Z; Shen K Gynecol Oncol; 2016 Dec; 143(3):526-531. PubMed ID: 27745918 [TBL] [Abstract][Full Text] [Related]
27. Endometriosis-associated ovarian cancer is a single entity with distinct clinicopathological characteristics. Li Q; Sun Y; Zhang X; Wang L; Wu W; Wu M; Meng C; Liu G Cancer Biol Ther; 2019; 20(7):1029-1034. PubMed ID: 30913953 [No Abstract] [Full Text] [Related]
28. Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study. Zhou L; Yao L; Dai L; Zhu H; Ye X; Wang S; Cheng H; Ma R; Liu H; Cui H; Chang X J Ovarian Res; 2021 May; 14(1):63. PubMed ID: 33941230 [TBL] [Abstract][Full Text] [Related]
29. Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Sainz de la Cuesta R; Eichhorn JH; Rice LW; Fuller AF; Nikrui N; Goff BA Gynecol Oncol; 1996 Feb; 60(2):238-44. PubMed ID: 8631545 [TBL] [Abstract][Full Text] [Related]
30. Ovarian and extraovarian endometriosis-associated cancer. Modesitt SC; Tortolero-Luna G; Robinson JB; Gershenson DM; Wolf JK Obstet Gynecol; 2002 Oct; 100(4):788-95. PubMed ID: 12383550 [TBL] [Abstract][Full Text] [Related]
31. Prognostic analysis of endometrioid epithelial ovarian cancer with or without endometriosis: a 12-year cohort study of Chinese patients. Wang S; Qiu L; Lang JH; Shen K; Huang HF; Pan LY; Wu M; Yang JX; Guo LN Am J Obstet Gynecol; 2013 Sep; 209(3):241.e1-9. PubMed ID: 23702297 [TBL] [Abstract][Full Text] [Related]
32. Synchronous endometrial and ovarian carcinomas: predictors of risk and associations with survival and tumor expression profiles. Kelemen LE; Rambau PF; Koziak JM; Steed H; Köbel M Cancer Causes Control; 2017 May; 28(5):447-457. PubMed ID: 28194593 [TBL] [Abstract][Full Text] [Related]
33. The ARID1A pathway in ovarian clear cell and endometrioid carcinoma, contiguous endometriosis, and benign endometriosis. Chene G; Ouellet V; Rahimi K; Barres V; Provencher D; Mes-Masson AM Int J Gynaecol Obstet; 2015 Jul; 130(1):27-30. PubMed ID: 25912412 [TBL] [Abstract][Full Text] [Related]
34. The clinical value of surgeons' efforts of preventing intraoperative tumor rupture in stage I clear cell carcinoma of the ovary: A Korean multicenter study. Suh DH; Park JY; Lee JY; Kim BG; Lim MC; Kim JW; Bae DS; Park SY; Nam JH; Kim K; No JH; Kim YB Gynecol Oncol; 2015 Jun; 137(3):412-7. PubMed ID: 25868967 [TBL] [Abstract][Full Text] [Related]
35. Long term survival of ovarian endometriosis associated clear cell and endometrioid ovarian cancers. Noli S; Cipriani S; Scarfone G; Villa A; Grossi E; Monti E; Vercellini P; Parazzini F Int J Gynecol Cancer; 2013 Feb; 23(2):244-8. PubMed ID: 23314280 [TBL] [Abstract][Full Text] [Related]
36. Endometriosis-associated ovarian malignancy: a retrospective analysis of presentation, treatment, and outcome. Garrett LA; Growdon WB; Goodman A; Boruta DM; Schorge JO; del Carmen MG J Reprod Med; 2013; 58(11-12):469-76. PubMed ID: 24568040 [TBL] [Abstract][Full Text] [Related]
37. Immunohistochemistry expression of targeted therapies biomarkers in ovarian clear cell and endometrioid carcinomas (type I) and endometriosis. Barreta A; Sarian LO; Ferracini AC; Costa LBE; Mazzola PG; de Angelo Andrade L; Derchain S Hum Pathol; 2019 Mar; 85():72-81. PubMed ID: 30447298 [TBL] [Abstract][Full Text] [Related]
38. Prognostic Factors of Early Stage Epithelial Ovarian Carcinoma. Hsieh SF; Lau HY; Wu HH; Hsu HC; Twu NF; Cheng WF Int J Environ Res Public Health; 2019 Feb; 16(4):. PubMed ID: 30795566 [TBL] [Abstract][Full Text] [Related]
39. Prognosis of Japanese patients with ovarian clear cell carcinoma associated with pelvic endometriosis: clinicopathologic evaluation. Komiyama S; Aoki D; Tominaga E; Susumu N; Udagawa Y; Nozawa S Gynecol Oncol; 1999 Mar; 72(3):342-6. PubMed ID: 10053105 [TBL] [Abstract][Full Text] [Related]
40. Ovarian nongestational choriocarcinoma mixed with various epithelial malignancies in association with endometriosis. Hirabayashi K; Yasuda M; Osamura RY; Hirasawa T; Murakami M Gynecol Oncol; 2006 Jul; 102(1):111-7. PubMed ID: 16527336 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]